This inventor holds 13 USPTO granted patents, primarily in Biomaterials Engineering. Top assignees: Institut Merieux, Imedex, Imedex Biomateriaux. Active years: 1981-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lyon, FR (1993)
- Lyons, FR (1981 - 2011)
Company Filing History:
5 out of 31 
4 out of 7 
1 out of 6 Years Active: 1981-2011
Areas of Expertise:
Title: The Innovative Journey of Inventor Michel A. Tardy
Introduction: Michel A. Tardy is a renowned inventor based in Lyons, France, holding an impressive portfolio of 13 patents. His work primarily focuses on advancements in biocompatible materials and viral purification methods, making significant contributions to medical technology.
Latest Patents: Among his latest inventions are two critical patents. The first, titled "Method for Purifying a Viral Suspension," introduces an innovative technique for obtaining viruses from a liquid viral suspension. The second patent addresses a "Collagenic Material Useful in Particular for Preventing Post-Operative Adhesions." This biocompatible collagenous material is designed to be non-toxic and biodegradable within less than a month, ideally in under a week. It consists of collagen and hydrophilic macromolecular additives that are chemically non-reactive with collagen, which has partially lost its helical structure and undergone crosslinking. This material is specifically intended for use in preventing post-operative adhesions.
Career Highlights: Throughout his career, Michel has collaborated with prominent institutions and organizations, including Institut Merieux and Imedex. His work in these companies has allowed him to develop and refine his inventions, contributing to advancements in healthcare and medical treatments.
Collaborations: Michel has worked alongside esteemed colleagues such as Jean-Louis Tayot and Henri Dumas. Their collaborative efforts have further propelled innovation in their respective fields, allowing them to tackle complex challenges in medical research and applications.
Conclusion: Michel A. Tardy's contributions as an inventor are noteworthy, with his innovative patents reflecting a commitment to enhancing healthcare solutions. His work on biocompatible materials and viral purification processes demonstrates a profound understanding of medical needs and illustrates the potential impact of his inventions on future medical practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile